Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2013. Start Trial.
Date Value
November 13, 2026 6.847
November 12, 2026 6.847
November 11, 2026 6.847
November 10, 2026 6.847
November 09, 2026 6.847
November 06, 2026 6.847
November 05, 2026 6.847
November 04, 2026 6.847
November 03, 2026 6.847
November 02, 2026 6.847
October 30, 2026 6.847
October 29, 2026 6.847
October 28, 2026 6.847
October 27, 2026 6.847
October 26, 2026 6.847
October 23, 2026 6.847
October 22, 2026 6.847
October 21, 2026 6.847
October 20, 2026 6.847
October 19, 2026 6.847
October 16, 2026 6.847
October 15, 2026 6.847
October 14, 2026 7.878
October 13, 2026 7.878
October 12, 2026 7.878
Date Value
October 09, 2026 7.878
October 08, 2026 7.962
October 07, 2026 7.962
October 06, 2026 7.962
October 05, 2026 7.624
October 02, 2026 7.624
October 01, 2026 7.624
September 30, 2026 7.350
September 29, 2026 7.350
September 28, 2026 7.350
September 25, 2026 7.059
September 24, 2026 7.059
September 23, 2026 7.059
September 22, 2026 7.059
September 21, 2026 7.059
September 18, 2026 7.059
September 17, 2026 7.059
September 16, 2026 7.059
September 15, 2026 7.059
September 14, 2026 7.059
September 11, 2026 7.059
September 10, 2026 7.059
September 09, 2026 7.059
September 08, 2026 7.059
September 04, 2026 7.059

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Healios KK 5.757
GNI Group Ltd. 2.497
AnGes, Inc. --
SanBio Co., Ltd. 6.201
ACADIA Pharmaceuticals, Inc. 2.335

Price to Book Value Related Metrics

PE Ratio 13.79
PS Ratio 3.477
Price 2.425
Earnings Yield 7.25%
Market Cap 310.35M
Operating PE Ratio 22.80